Literature DB >> 21647551

The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.

Zuo-Lin Xiang1, Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian He, Hai-Ying Zeng, Joe Y Chang.   

Abstract

The purpose of this study was to evaluate the relationship between hypoxia-inducible factor-1α (HIF-1α) protein expression in hepatocellular carcinoma (HCC), and responses of abdominal metastatic lymph nodes (LNs) from HCC patients treated with external beam radiotherapy (EBRT). HIF-1α immunohistochemical staining was performed on tissue microarrays (TMAs) of primary HCC specimens from 69 HCC patients with abdominal LN metastases. All patients received abdominal metastatic LN EBRT at the Department of Radiation Oncology at Zhongshan Hospital. A receiver-operating characteristic (ROC)-based approach and logistical regression analysis were used to determine the predictive value of HIF-1α expression in primary tumors with HCC metastatic LN EBRT response. Kaplan-Meier curves and log-rank tests were used to analyze patient survival. Cox proportional hazards regression model was used to analyze independent prognostic factors. HIF-1α expression was correlated with blood hemoglobin (Hb: r = -0.280, P = 0.020), response of abdominal metastatic LNs to EBRT (r = 0.286, P = 0.017), locoregional recurrence (r = 0.278, P = 0.021), and cancer-specific deaths (r = 0.298, P = 0.013). HIF-1α expression was predictive of EBRT response of metastatic LNs [area under the curve (AUC): 0.646; 95% confidence interval (CI): 0.499-0.793; P = 0.047], locoregional recurrence (AUC: 0.657; 95% CI: 0.509-0.805; P = 0.049) and cancer-specific deaths (AUC: 0.671; 95% CI: 0.531-0.812; P = 0.035). Patients with tumors exhibiting high HIF-1α expression had significantly poorer overall survival (OS) than those with low tumor expression of HIF-1α (P = 0.016). Multivariate analysis showed that Hb (P = 0.035), vascular invasion (P = 0.026), Child-Pugh score (P < 0.001), intrahepatic tumor control (P < 0.001), and HIF-1α (P = 0.020) were independent prognosis factors for OS of HCC patients after receiving abdominal metastatic LN EBRT. HIF-1α expression in primary HCCs was associated with EBRT response of abdominal metastatic LNs and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647551     DOI: 10.1007/s11033-011-0949-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.

Authors:  Yong-Bing Qian; Ju-Bo Zhang; Wei-Zhong Wu; Hong-Bin Fang; Wei-Dong Jia; Peng-Yuan Zhuang; Bo-Heng Zhang; Qi Pan; Yang Xu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  Cancer       Date:  2006-10-01       Impact factor: 6.860

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Hui-Chuan Sun; Yun-Shan Tan
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

Review 4.  Impact of hemoglobin levels on tumor oxygenation: the higher, the better?

Authors:  Peter Vaupel; Arnulf Mayer; Michael Höckel
Journal:  Strahlenther Onkol       Date:  2006-02       Impact factor: 3.621

5.  Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.

Authors:  Erdenebulgan Batmunkh; Mitsuo Shimada; Yuji Morine; Satoru Imura; Hirofumi Kanemura; Yusuke Arakawa; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Masaaki Nishi
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

Review 6.  Tumor microenvironmental physiology and its implications for radiation oncology.

Authors:  Peter Vaupel
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

7.  Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.

Authors:  James S Michaelson; L Leon Chen; Melvin J Silverstein; Justin A Cheongsiatmoy; Martin C Mihm; Arthur J Sober; Kenneth K Tanabe; Barbara L Smith; Jerry Younger
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

8.  Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer.

Authors:  Priyamal Silva; Nick J Slevin; Philip Sloan; Helen Valentine; Jo Cresswell; David Ryder; Patricia Price; Jarrod J Homer; Catharine M L West
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-01       Impact factor: 7.038

9.  Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.

Authors:  Tomofumi Yohena; Ichiro Yoshino; Tomoyoshi Takenaka; Toshifumi Kameyama; Taro Ohba; Yukio Kuniyoshi; Yoshihiko Maehara
Journal:  J Thorac Oncol       Date:  2009-03       Impact factor: 15.609

10.  Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.

Authors:  Chen-Xin Dai; Qiang Gao; Shuang-Jian Qiu; Min-Jie Ju; Ming-Yan Cai; Yong-Feng Xu; Jian Zhou; Bo-Heng Zhang; Jia Fan
Journal:  BMC Cancer       Date:  2009-12-01       Impact factor: 4.430

View more
  29 in total

1.  HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT.

Authors:  Yang Liu; Yawei Liu; Xiaolu Yan; Yuan Xu; Fei Luo; Jing Ye; Han Yan; Xiaojun Yang; Xiaodan Huang; Jianping Zhang; Guozhong Ji
Journal:  Tumour Biol       Date:  2014-05-20

2.  Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Jia Fan; Zhao-You Tang; Hai-Ying Zeng
Journal:  Mol Biol Rep       Date:  2011-12-29       Impact factor: 2.316

3.  Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.

Authors:  Nisreen A A Osman; Dalia M Abd El-Rehim; Inas M Kamal
Journal:  Tumour Biol       Date:  2015-01-17

Review 4.  Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.

Authors:  Daniel Lin; Jennifer Wu
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Clinical and prognostic significance of HIF-1α in glioma patients: a meta-analysis.

Authors:  Qi Liu; Peicheng Cao
Journal:  Int J Clin Exp Med       Date:  2015-12-15

6.  Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.

Authors:  Sheng-Li Yang; Li-Ping Liu; Yun-Fan Sun; Xing-Rong Yang; Jia Fan; Jian-Wei Ren; George G Chen; Paul B S Lai
Journal:  J Gastroenterol       Date:  2015-11-25       Impact factor: 7.527

7.  Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factors.

Authors:  Ping Liu; Xiefan Fang; Yang Song; Jian-Xin Jiang; Qian-Jin He; Xiang-Jie Liu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

8.  Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1α to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats.

Authors:  Jinwen Xu; Qiuling Xiang; Guiping Lin; Xiaodong Fu; Kewen Zhou; Ping Jiang; Shuhui Zheng; Tinghuai Wang
Journal:  Mol Biol Rep       Date:  2012-05-09       Impact factor: 2.316

9.  Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.

Authors:  Shereen El Shorbagy; Fouad abuTaleb; Hany A Labib; Huda Ebian; Ola A Harb; Mona Saeed Mohammed; Hanaa A Rashied; Khaled A Elbana; Rasha Haggag
Journal:  J Gastrointest Cancer       Date:  2021-03

10.  Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma.

Authors:  Mahmoud Ma Elsayed; Mahmoud E Mostafa; Eman Alaaeldin; Hatem Aa Sarhan; Montaser ShA Shaykoon; Shady Allam; Ahmed Rh Ahmed; Bakheet Em Elsadek
Journal:  Int J Nanomedicine       Date:  2019-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.